The World Health Organization (WHO) dubbed the Zika virus a global health emergency on Feb. 1, 2016 without detailing much about the disease. In fact, most of the public do not know that it is patented.
Zika, which is a sexually transmitted virus, has existed for many years, and is marketed by two companies: Middlesex, United Kingdom-based cell and microbiology cultures provider LGC Standards Ltd. and Manassas, Virginia-based reference microorganisms provider American Type Culture Collection (ATCC).
Now comes the question of who owns the patent of the Zika virus.
The Zika virus is a commodity that had been purchased online from the ATCC-LGC partnership for 599 euros by The Rockefeller Foundation. American banker and Chase Manhattan Corp. former chairman and chief executive David Rockefeller, in an address to a Trilateral Commission Meeting in June 1991, said: “It would have been impossible for us to develop our plan for the world if we had been subjected to the lights of publicity during those years. But, the world is more sophisticated and prepared to march towards a world government. The supernational sovereignty of an intellectual elite and world bankers is surely preferable to the national auto-determination practiced in past centuries.”
In 1947, researchers from The Rockefeller Foundation placed a rhesus monkey in a cage in the middle of the Zika Forest in Uganda. The research team was investigating possible causes of yellow fever, but instead of finding more about it, they made a discovery: Rhesus 766 would ultimately become known as the first carrier of the Zika virus.